Literature DB >> 23971630

The signaling pathway of hypoxia inducible factor and its role in renal diseases.

Song Mao1, Songming Huang.   

Abstract

It is well-documented that hypoxia inducible factor (HIF) is a key mediator of tissue and cellular adaptation to hypoxia. HIF-target genes are also involved in cellular apoptosis and profibrotic mechanisms. The role of HIF in diseases is not consistent. It is a risk factor for tumor progression, whereas it plays a protective role against ischemic hypofusion. For renal diseases, it is not always a risk or protective factor. Many factors are involved in the pathogenesis of renal diseases. It is reported that HIF not only increases hypoxia tolerance, but also regulates a lot of signaling pathways. In the past decades, a number of studies were also conducted to explore the association between HIF and the risk of renal diseases. However, the role of HIF in the development of renal diseases was not entirely clear. In this study, the signal transduction pathways of HIF and its role in the pathogenesis of renal diseases were reviewed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23971630     DOI: 10.3109/10799893.2013.830130

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  4 in total

1.  miR-210 protects renal cell against hypoxia-induced apoptosis by targeting HIF-1 alpha.

Authors:  Li-Li Liu; Dahu Li; Yun-Ling He; Yan-Zhao Zhou; Sheng-Hui Gong; Li-Ying Wu; Yong-Qi Zhao; Xin Huang; Tong Zhao; Lun Xu; Kui-Wu Wu; Ming-Gao Li; Ling-Ling Zhu; Ming Fan
Journal:  Mol Med       Date:  2017-10-16       Impact factor: 6.354

2.  Hypoxic renal injury in newborns with abdominal compartment syndrome (clinical and experimental study).

Authors:  Dmitry Morozov; Olga Morozova; Dmitri Pervouchine; Lubov Severgina; Alexei Tsyplakov; Natalya Zakharova; Nikita Sushentsev; Larisa Maltseva; Ivan Budnik
Journal:  Pediatr Res       Date:  2017-11-15       Impact factor: 3.756

3.  Bicalutamide Elicits Renal Damage by Causing Mitochondrial Dysfunction via ROS Damage and Upregulation of HIF-1.

Authors:  Kuan-Chou Chen; Chang-Rong Chen; Chang-Yu Chen; Kai-Yi Tzou; Chiung-Chi Peng; Robert Y Peng
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

4.  The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13.

Authors:  Pauline Hascoet; Franck Chesnel; Florence Jouan; Cathy Le Goff; Anne Couturier; Eric Darrigrand; Fabrice Mahe; Nathalie Rioux-Leclercq; Xavier Le Goff; Yannick Arlot-Bonnemains
Journal:  Oncotarget       Date:  2017-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.